Sanofi, Elan rise on M&A talk

Sanofi-Aventis and Elan saw their stocks leap yesterday on deal rumors: Speculation that Sanofi may buy Merck's interest in its animal-health joint venture Merial sent its shares flying, while rumors that Pfizer might buy Elan boosted the Irish company's stock. Report | Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.